ESCMID: Treatment Failure Does Not Differ Between Amoxicillin, Amoxicillin-Clavulanate for Acute Sinusitis

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 22, 2026.

via HealthDay

WEDNESDAY, April 22, 2026 -- For adults with acute sinusitis treated in the outpatient setting, there is no difference in treatment failure with standard-dose amoxicillin-clavulanate or standard-dose amoxicillin, according to a study published online April 18 in the Journal of the American Medical Association to coincide with the annual European Society of Clinical Microbiology and Infectious Diseases Global Congress, held from April 17 to 21 in Munich.

Timothy J. Savage, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues compared the risk for treatment failure and adverse events between standard-dose amoxicillin-clavulanate versus standard-dose amoxicillin for adults aged 18 to 64 years with outpatient acute sinusitis.

The full cohort included 521,244 adults; there were 234,608 patients after propensity score matching (117,304 in each group). The researchers found that 3.1 percent of patients had treatment failure and 0.03 percent required an emergency department or inpatient encounter. The risk for treatment failure did not differ between the amoxicillin-clavulanate and amoxicillin groups (3.0 versus 3.1 percent); this finding was consistent across sensitivity analyses. Antibiotic-associated adverse events did not differ between the groups (1.3 versus 1.2 percent). Higher risks for secondary infections were seen for amoxicillin-clavulanate versus amoxicillin, including yeast infections (1.1 versus 0.8 percent) and Clostridioides difficile infections (0.04 versus 0.02 percent).

"We found no observed benefit to using amoxicillin-clavulanate, which supports standard‑dose amoxicillin as the preferred choice for adults with uncomplicated acute sinusitis," Savage said in a statement.

Two authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-23 02:08

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords